Skip to main content
Log in

Single-Chamber and Dual-Chamber Pacemaker Devices in Adults with Moderate and Complex Congenital Heart Disease: A Single Tertiary Referral Center Experience

  • Research
  • Published:
Pediatric Cardiology Aims and scope Submit manuscript

Abstract

The number of device implantation procedures has increased in adult patients with congenital heart disease (ACHD). Despite significant improvements in materials and implantation techniques, these patients are exposed to higher risk of device related complications than general population. Herein, we describe our single tertiary referral center experience on transvenous pacemaker (PM) implantation and follow-up in adult patients with moderate and complex congenital heart disease (CHD) as limited data are available on long-term outcome. We considered all adults with moderate and complex CHD aged more than 16 years who underwent transvenous single-chamber and dual-chamber PM implant for sinus node dysfunction or atrioventricular block between January 2013 to December 2022 at our Unit. Seventy-one ACHD patients were included in the study (mean age 38.6 ± 15.2 years, 64% with moderate CHD, 36% with complex CHD). Among 32 patients implanted with a dual chamber PM (DDD PM), 4 devices were reprogrammed in VDD mode, 3 in VVI and 2 in AAI mode during follow-up because of lead dysfunction or permanent atrial arrhythmia. In addition, 26 patients had a single chamber PM (AAI or VVI PM) and 13 patients had single-lead pacing system with a free-floating atrial electrode pair (VDD PM). Just one of 13 single-lead VDD PM was reprogrammed in VVI mode due to a low atrial sensing. In DDD PM group, 10 re-interventions were needed due to lead dysfunction (8 cases) and lead-related infective endocarditis (2 cases). Only 3 patients in the single-lead PM group developed lead dysfunction with 2 re-interventions needed, but no infective endocarditis was reported. The rate of long-term complications is high in moderate and complex ACHD with transvenous PM devices, and it is mainly lead-related. In our experience, the less leads implanted, the less complications will occur. Considering the heterogeneity of the ACHD population, transvenous single-chamber or dual-chamber PM device implantation should always be tailored on the single patient, balancing risks and benefits in this complex population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data Availability

No datasets were generated or analysed during the current study.

References

  1. Liu Y, Chen S, Zühlke L, Black GC, Choy MK, Li N, Keavney BD (2019) Global birth prevalence of congenital heart defects 1970–2017: updated systematic review and meta-analysis of 260 studies. Int J Epidemiol 48(2):455–463. https://doi.org/10.1093/ije/dyz009PMID: 30783674; PMCID: PMC6469300

    Article  PubMed  PubMed Central  Google Scholar 

  2. Barracano R, Ciriello GD, Sarubbi B (2023) Pharmacological therapy in adult congenital heart disease with coronary artery disease and atrial fibrillation. Int J Cardiol Congenital Heart Disease 12:2666–6685. https://doi.org/10.1016/j.ijcchd.2023.100446

    Article  Google Scholar 

  3. Brida M, Gatzoulis MA (2019) Adult congenital heart disease: past, present and future. Acta Paediatr 108(10):1757–1764. https://doi.org/10.1111/apa.14921Epub 2019 Aug 18. PMID: 31254360

    Article  PubMed  Google Scholar 

  4. Anderson RH, Ho SY (1991) The disposition of the conduction tissues in congenitally malformed hearts with reference to their embryological development. J Perinat Med 19(Suppl 1):201–206

    PubMed  Google Scholar 

  5. Limongelli G, Ducceschi V, D’Andrea A, Renzulli A, Sarubbi B, De Feo M, Cerasuolo F, Calabrò R, Cotrufo M (2003) Risk factors for pacemaker implantation following aortic valve replacement: a single centre experience. Heart 89(8):901–904. https://doi.org/10.1136/heart.89.8.901PMID: 12860869; PMCID: PMC1767749

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Sarubbi B, Ciriello GD, Papaccioli G et al (2023) Combined subcutaneous implantable cardioverter defibrillator and pacemaker devices in complex congenital heart disease. A single-center experienced based study. Authorea January 30. https://doi.org/10.22541/au.167507359.94643473/v1

  7. Li W, Sarubbi B, Somerville J (2000) Iatrogenic ventricular tachycardia from endocardial pacemaker late after repair of tetralogy of Fallot. Pacing Clin Electrophysiol.;23(12):2131-4. https://doi.org/10.1111/j.1540-8159.2000.tb00789.x. PMID: 11202260

  8. Hernández-Madrid A, Paul T, Abrams D, Aziz PF, Blom NA, Chen J, Chessa M, Combes N, Dagres N, Diller G, Ernst S, Giamberti A, Hebe J, Janousek J, Kriebel T, Moltedo J, Moreno J, Peinado R, Pison L, Rosenthal E, Skinner JR, Zeppenfeld K, ESC Scientific Document Group (2018);. Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE. Europace.;20(11):1719–1753. https://doi.org/10.1093/europace/eux380. PMID: 29579186

  9. Baumgartner H, De Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller G-P, Kluin BlungJ, Irene M, Lang F, Meijboom P, Moons, Barbara JM, Mulder E, Oechslin JW, Roos-Hesselink M, Schwerzmann L, Sondergaard K, Zeppenfeld, February, ESC Scientific Document Group (2021), 2020 ESC Guidelines for the management of adult congenital heart disease: The Task Force for the management of adult congenital heart disease of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Adult Congenital Heart Disease (ISACHD), European Heart Journal, Volume 42, Issue 6, 7 Pages 563–645, https://doi.org/10.1093/eurheartj/ehaa554

  10. Glikson M, Nielsen JC, Kronborg MB et al (2021) 2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J 42(35):3427–3520

    Article  PubMed  Google Scholar 

  11. Stout KK, Daniels CJ, Aboulhosn JA et al (2019) 2018 AHA/ACC Guideline for the management of adults with congenital heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice guidelines. J Am Coll Cardiol 73(12):1494–1563

    Article  PubMed  Google Scholar 

  12. Cecchin DG, Halpern (2017) Cardiac arrhythmias in adults with congenital heart disease: pacemakers, implantable cardiac defibrillators, and cardiac resynchronization therapy devices. Card Electrophysiol Clin 9:319–328

  13. Lin A, Mahle WT, Frias PA, Fischbach PS, Kogon BE, Kanter KR et al (2010) Early and delayed atrioventricular conduction block after routine surgery for congenital heart disease. J Thorac Cardiovasc Surg 140:158–160

    Article  PubMed  Google Scholar 

  14. Sarubbi B, Mercurio B, Ducceschi V, Russo MG, Calabrò R (2004) A multisite atrioventricular block. Ital Heart J 5(1):64–68 PMID: 15080584

    PubMed  Google Scholar 

  15. Broberg CS, van Dissel A, Minnier J, Aboulhosn J, Kauling RM, Ginde S, Krieger EV, Rodriguez F 3rd, Gupta T, Shah S, John AS, Cotts T, Kay WA, Kuo M, Dwight C, Woods P, Nicolarsen J, Sarubbi B, Fusco F, Antonova P, Fernandes S, Grewal J, Cramer J, Khairy P, Gallego P, O’Donnell C, Hannah J, Dellborg M, Rodriguez-Monserrate CP, Muhll IV, Pylypchuk S, Magalski A, Han F, Lubert AM, Kay J, Yeung E, Roos-Hesselink J, Baker D, Celermajer DS, Burchill LJ, Wilson WM, Wong J, Kutty S, Opotowsky AR (2022) Long-Term Outcomes After Atrial Switch Operation for Transposition of the Great Arteries. J Am Coll Cardiol.;80(10):951–963. https://doi.org/10.1016/j.jacc.2022.06.020. PMID: 36049802

  16. Greenwood RD, Rosenthal A, Sloss LJ, LaCorte M, Nadas AS (1975) Sick sinus syndrome after surgery for congenital heart disease. Circulation.;52(2):208 – 13. https://doi.org/10.1161/01.cir.52.2.208. PMID: 1149204

  17. Murphy JG, Gersh BJ, McGoon MD et al (1990) Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years. N Engl J Med 323(24):1645–1650

    Article  CAS  PubMed  Google Scholar 

  18. Cohen MI, Bridges ND, Gaynor JW et al (2000) Modifications to the cavopulmonary anastomosis do not eliminate early sinus node dysfunction. J Thorac Cardiovasc Surg 120:891–901

    Article  CAS  PubMed  Google Scholar 

  19. Peters NS, Somerville J (1992) Arrhythmias after the Fontan procedure. Br Heart J 68(2):199–204

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Opić P, van Kranenburg M, Yap SC et al (2013) Complications of pacemaker therapy in adults with congenital heart disease: a multicenter study. Int J Cardiol 168(4):3212–3216

    Article  PubMed  Google Scholar 

  21. Walker F, Siu SC, Woods S, Cameron DA, Webb GD, Harris L (2004) Long-term outcomes of cardiac pacing in adults with congenital heart disease. J Am Coll Cardiol 43:1894–1901. https://doi.org/10.1016/j.jacc.2003.12.044

    Article  PubMed  Google Scholar 

  22. Midha D, Chen Z, Jones DG et al (2017) Pacing in congenital heart disease - A four-decade experience in a single tertiary centre. Int J Cardiol 241:177–181

    Article  PubMed  Google Scholar 

  23. Bowman HC, Shannon KM, Biniwale R, Moore JP (2021) Cardiac implantable device outcomes and lead survival in adult congenital heart disease. Int J Cardiol 324:52–59. https://doi.org/10.1016/j.ijcard.2020.09.027Epub 2020 Sep 15. PMID: 32941867

    Article  PubMed  Google Scholar 

  24. Silvetti MS, Drago F, Grutter G, De Santis A, Di Ciommo V, Ravà L (2006) Twenty years of paediatric cardiac pacing: 515 pacemakers and 480 leads implanted in 292 patients. Europace.;8(7):530-6. https://doi.org/10.1093/europace/eul062. PMID: 16798767

Download references

Acknowledgements

Special thanks to the nursing staff of the Adult Congenital Heart Disease Unit, and specially to the head nurs,e Mrs. Assunta Carandente, for their essential contribution and support in maintaining a high-quality standard of care for our complex patients. Additionally, we express our gratitude to Dr. Gabriella Piccolo, Dr. Nadia Puzone, Dr. Cecilia Spinelli Barrile and Dr. Tiziana Varriale, the data manager and research assistants, for their efforts in data collection and analysis, as well as their support in remote control monitoring.

Funding

No funding was received for conducting this study.

Author information

Authors and Affiliations

Authors

Contributions

GP, FLR and BS contributed to write, review, and image editing. NG, AO and GDC contributed to data collection and review. AC, DC, ER and MP contributed to production of tables/figures and review. All authors approved the manuscript text.

Corresponding author

Correspondence to Giovanni Papaccioli.

Ethics declarations

Competing Interests

The authors have no financial or proprietary interests in any material discussed in this article.

Ethics Approval and Consent

The study received approval from the local ethics committee and conformed to the ethical guidelines of the 1975 Declaration of Helsinki and its later amendments. Informed consent was obtained from all patients or their guardians.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Papaccioli, G., Rocca, F.L., Ciriello, G.D. et al. Single-Chamber and Dual-Chamber Pacemaker Devices in Adults with Moderate and Complex Congenital Heart Disease: A Single Tertiary Referral Center Experience. Pediatr Cardiol (2024). https://doi.org/10.1007/s00246-024-03444-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00246-024-03444-6

Keywords

Navigation